Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose.
Hyperglycemia is a causal factor in the development of the vascular complications of diabetes. One of the biochemical mechanisms activated by excess glucose is the polyol pathway, the key enzyme of which, aldose reductase, transforms d-glucose into d-sorbitol, leading to imbalances of intracellular homeostasis. We aimed at verifying the effects of thiamine and benfotiamine on the polyol pathway, transketolase activity, and intracellular glucose in endothelial cells and pericytes under high ambient glucose. Human umbilical vein endothelial cells and bovine retinal pericytes were cultured in normal (5.6 mmol/liter) or high (28 mmol/liter) glucose, with or without thiamine or benfotiamine 50 or 100 mumol/liter. Transketolase and aldose reductase mRNA expression was determined by reverse transcription-PCR, and their activity was measured spectrophotometrically; sorbitol concentrations were quantified by gas chromatography-mass spectrometry and intracellular glucose concentrations by fluorescent enzyme-linked immunosorbent assay method. Thiamine and benfotiamine reduce aldose reductase mRNA expression, activity, sorbitol concentrations, and intracellular glucose while increasing the expression and activity of transketolase, for which it is a coenzyme, in human endothelial cells and bovine retinal pericytes cultured in high glucose. Thiamine and benfotiamine correct polyol pathway activation induced by high glucose in vascular cells. Activation of transketolase may shift excess glycolytic metabolites into the pentose phosphate cycle, accelerate the glycolytic flux, and reduce intracellular free glucose, thereby preventing its conversion to sorbitol. This effect on the polyol pathway, together with other beneficial effects reported for thiamine in high glucose, could justify testing thiamine as a potential approach to the prevention and/or treatment of diabetic complications.
Berrone
Elena
E
Department of Internal Medicine, University of Turin, I-10126 Turin, Italy. elena.berrone@unito.it
Beltramo
Elena
E
Solimine
Carmela
C
Ape
Alessandro Ubertalli
AU
Porta
Massimo
M
D000449:Aldehyde Reductase / Q000096:biosynthesis / Q000378:metabolism*; D000818:Animals; D002417:Cattle; D018929:Cell Culture Techniques; D002614:Chelating Agents / Q000494:pharmacology*; D003930:Diabetic Retinopathy / Q000503:physiopathology / Q000517:prevention & control; D042783:Endothelial Cells / Q000502:physiology; D004797:Enzyme-Linked Immunosorbent Assay; D005947:Glucose / Q000378:metabolism*; D006706:Homeostasis; D006801:Humans; D006943:Hyperglycemia / Q000150:complications / Q000503:physiopathology; D020286:Pericytes / Q000502:physiology; D011108:Polymers; D017382:Reactive Oxygen Species; D012160:Retina / Q000166:cytology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013012:Sorbitol / Q000378:metabolism; D013831:Thiamine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000502:physiology*; D014174:Transketolase / Q000378:metabolism; D014470:Umbilical Cord / Q000098:blood supply
D002614:Chelating Agents; D011108:Polymers; D017382:Reactive Oxygen Species; C024617:polyol; D013012:Sorbitol; D000449:Aldehyde Reductase; D014174:Transketolase; D005947:Glucose; D013831:Thiamine; C013835:benphothiamine